Source: IsoPlexis Blog

IsoPlexis Blog Pushing the Boundaries in Cell Line Development: Webinar Recap

This past February and March, Bruker Cellular Analysis, in partnership with BioProcess International, hosted a dynamic two-part webinar series - Pushing the Boundaries in Cell Line Development - spotlighting the capabilities of the Beacon® Optofluidic platform for cell line development (CLD). Now available on demand, these sessions offer a front-row view into how cutting-edge technology [...]The post Pushing the Boundaries in Cell Line Development: Webinar Recap appeared first on Bruker Cellular Analysis.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Sean Mackay's photo - Co-Founder & CEO of IsoPlexis

Co-Founder & CEO

Sean Mackay

CEO Approval Rating

89/100

Read more